Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ESOMEPRAZOLE MAGNESIUM

ESOMEPRAZOLE MAGNESIUM

Standard Dose
EQ 40MG BASE/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ESOMEPRAZOLE MAGNESIUM is listed in Drugs@FDA under application 218948 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ESOMEPRAZOLE MAGNESIUM Form and strength FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-04-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESOMEPRAZOLE MAGNESIUM is listed in Drugs@FDA under application 218948 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESOMEPRAZOLE MAGNESIUM Form and strength FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-04-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.